I.M. Sechenov First Moscow State Medical University
sechenov.ruTotal trials
132
Active
24
Phase 3
1
Total enrollment
39,310
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Longidaza | — | — | — | — | — | 1 | |
| Metronidazole 500 mg | — | — | — | — | — | 1 | |
| Rifaximin | — | — | — | — | — | 1 | |
| Standart medical treatment | — | — | — | — | — | 1 |
Next readouts
- 2025-06-01
- 2026-06
- 2026-09-30
Top conditions
- Coronary Artery Disease6
- Heart Failure6
- COVID-195
- Prostate Cancer5
- Quality of Life4
- Arterial Hypertension4
- Soft Tissue Atrophy4
- Prostate Adenocarcinoma4
Frequently asked questions about I.M. Sechenov First Moscow State Medical University
- How many clinical trials does I.M. Sechenov First Moscow State Medical University have on ClinicalTrials.gov?
- I.M. Sechenov First Moscow State Medical University is listed as the lead sponsor on 132 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of I.M. Sechenov First Moscow State Medical University's trials are in Phase 3?
- 1 of I.M. Sechenov First Moscow State Medical University's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does I.M. Sechenov First Moscow State Medical University focus on?
- I.M. Sechenov First Moscow State Medical University's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Heart Failure, COVID-19, Prostate Cancer, Quality of Life.
- When are I.M. Sechenov First Moscow State Medical University's next clinical trial readouts?
- I.M. Sechenov First Moscow State Medical University has 3 upcoming primary-completion readouts tracked here; the soonest is “Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age”, expected around 2025-06-01.